397 related articles for article (PubMed ID: 31248309)
1. Recent advances in molecular biomarkers for patients with hepatocellular carcinoma.
Umeda S; Kanda M; Kodera Y
Expert Rev Mol Diagn; 2019 Aug; 19(8):725-738. PubMed ID: 31248309
[No Abstract] [Full Text] [Related]
2. Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.
Niu ZS; Niu XJ; Wang WH
World J Gastroenterol; 2017 Aug; 23(32):5860-5874. PubMed ID: 28932078
[TBL] [Abstract][Full Text] [Related]
3. Noncoding RNA as therapeutic targets for hepatocellular carcinoma.
George J; Patel T
Semin Liver Dis; 2015 Feb; 35(1):63-74. PubMed ID: 25632936
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
Qiu L; Tang Q; Li G; Chen K
Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
[TBL] [Abstract][Full Text] [Related]
5. Non-coding RNA in drug resistance of hepatocellular carcinoma.
Ding B; Lou W; Xu L; Fan W
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
[TBL] [Abstract][Full Text] [Related]
6. Non-coding RNAs in Various Stages of Liver Disease Leading to Hepatocellular Carcinoma: Differential Expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno/mt-RNAs.
Koduru SV; Leberfinger AN; Kawasawa YI; Mahajan M; Gusani NJ; Sanyal AJ; Ravnic DJ
Sci Rep; 2018 May; 8(1):7967. PubMed ID: 29789629
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel biomarkers for hepatocellular carcinoma using transcriptome analysis.
Xia Q; Li Z; Zheng J; Zhang X; Di Y; Ding J; Yu D; Yan L; Shen L; Yan D; Jia N; Chen W; Feng Y; Wang J
J Cell Physiol; 2019 Apr; 234(4):4851-4863. PubMed ID: 30272824
[TBL] [Abstract][Full Text] [Related]
8. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
[TBL] [Abstract][Full Text] [Related]
9. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.
Qiu L; Xu H; Ji M; Shang D; Lu Z; Wu Y; Tu Z; Liu H
Life Sci; 2019 Aug; 231():116660. PubMed ID: 31319086
[TBL] [Abstract][Full Text] [Related]
10. The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment.
Shi T; Morishita A; Kobara H; Masaki T
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638971
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis.
Zhang M; Wang W; Li T; Yu X; Zhu Y; Ding F; Li D; Yang T
Biomed Pharmacother; 2016 May; 80():73-79. PubMed ID: 27133041
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?
Gnoni A; Santini D; Scartozzi M; Russo A; Licchetta A; Palmieri V; Lupo L; Faloppi L; Palasciano G; Memeo V; Angarano G; Brunetti O; Guarini A; Pisconti S; Lorusso V; Silvestris N
Expert Opin Ther Targets; 2015; 19(12):1623-35. PubMed ID: 26212068
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNAs in liver cancer: what we know in 2014.
Zhao J; Greene CM; Gray SG; Lawless MW
Expert Opin Ther Targets; 2014 Oct; 18(10):1207-18. PubMed ID: 25145388
[TBL] [Abstract][Full Text] [Related]
14. Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review.
Oura K; Morishita A; Masaki T
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171811
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
Peng W; Fan H
Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
17. Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma.
Li C; Chen J; Zhang K; Feng B; Wang R; Chen L
Cell Physiol Biochem; 2015; 36(2):423-34. PubMed ID: 25968300
[TBL] [Abstract][Full Text] [Related]
18. Role of miRNA sponges in hepatocellular carcinoma.
Li D; Zhang J; Li J
Clin Chim Acta; 2020 Jan; 500():10-19. PubMed ID: 31604064
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
20. The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment.
D'Anzeo M; Faloppi L; Scartozzi M; Giampieri R; Bianconi M; Del Prete M; Silvestris N; Cascinu S
Molecules; 2014 May; 19(5):6393-406. PubMed ID: 24853455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]